SB

Sandip Babudas Bairagi

Active Director Director DIN 10887223
DIN 10887223 First appointment Dec 2024 Primary industry Paper
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Sandip Babudas Bairagi

Data last updated:

Sandip Babudas Bairagi is a Director at Sanjeevan Pharmachem Private Limited (since 2024). The company operates in Paper.

DIN 10887223
Primary Designation Director
Industry Paper
First Appointment 26 Dec 2024
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Sanjeevan Pharmachem Private Limited U21000MH2024PTC437126
Director26 Dec 20242024Active

Board colleagues of Sandip Babudas Bairagi

NameDINCompanyDesignation
Jeevan Raghunath Gore10887224Sanjeevan Pharmachem Private LimitedDirector

Directorship timeline

Open interactive timeline →
Sanjeevan Pharmachem Private Limited
Premium access

Shareholding and investment profile for Sandip Babudas Bairagi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sandip Babudas Bairagi

Sandip Babudas Bairagi currently holds 1 directorship: Sanjeevan Pharmachem Private Limited (Director, since 26 Dec 2024).

Sandip Babudas Bairagi was first appointed on 26 Dec 2024 as Director at Sanjeevan Pharmachem Private Limited.

The current boards of Sandip Babudas Bairagi's companies include Jeevan Raghunath Gore (Sanjeevan Pharmachem Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available